Results 141 to 150 of about 4,655,222 (236)

Subsequent Thromboembolic and Bleeding Events in Patients With Major Bleeding While on Factor Xa Inhibitors. [PDF]

Circ Rep
Suzuki T, Yasaka M, Wada F, Ide R, Suzuki K, Kohsaka S.   +5 more
europepmc   +1 more source

A cofactor‐promiscuous HMGR from the Lyme disease pathogen illuminates diversity in bacterial isoprenoid biosynthesis

Protein Science, Volume 35, Issue 9, September 2026.
Abstract The Lyme disease pathogen Borrelia burgdorferi contains a highly reduced genome lacking many primary metabolic pathways. However, B. burgdorferi retains the mevalonate pathway that synthesizes isopentenyl pyrophosphate (IPP), the precursor to the peptidoglycan carrier lipid.
Isaac A. Paddy, Joshua McCausland, Madelyn Frazier, Poulami Chatterjee, Mekedlawit Setegne, Oliv Eidam, Christine Jacobs‐Wagner, Laura M. K. Dassama   +7 more
wiley   +1 more source

Residue‑resolved dynamically averaged interaction analysis of direct factor Xa inhibitors by MD‑FMO combination calculations. [PDF]

J Comput Aided Mol Des
Yoshine R, Hirano Y, Doi H, Kitahara S, Akisawa K, Okuwaki K, Yamamoto E, Yasuoka K, Mochizuki Y.   +8 more
europepmc   +1 more source

Synergistic Effect of Hydrophilic Surface and Nano‐Ag2O in TiO2‐Based Composites Coating on Antibacterial and Osteogenic Properties of Low Modulus Ti‐Mo‐Ag Alloy

Rare Metals, Volume 45, Issue 9, September 2026.
ABSTRACT Ti‐15Mo‐2.5Ag alloy exhibited a low modulus and strong antibacterial ability but poor bioactivity. To resolve this problem, sandblasting and anodization were used to create a hydrophilic and nano‐Ag2O‐containing TiO2 coating. Subsequently, the microstructure and physicochemical properties were investigated by scanning electron microscopy, X ...
Yanchun Xie, Junfan Chen, Ming Zhang, Zixin Lin, Hailong Yu, Anwu Xuan, Yi Lian, Lei Yang, Yong Wang, Yuxin Liu, Erlin Zhang, Bing Bai   +11 more
wiley   +1 more source

Kidney injury associated with direct oral anticoagulants: a comparative study of direct thrombin inhibitors and factor Xa inhibitors based on literature and database analysis. [PDF]

Ren Fail
Chen S, Shi C, Li X, Wang X, Guo R, Wu T.   +5 more
europepmc   +1 more source

Perfluorohexanone for Clean Fire Suppression: Mechanisms, System Design, Applications, and Future Directions

Safety Science and Technology, Volume 1, Issue 3, September 2026.
Driven by halon and high GWP agent phase out, perfluorohexanone is increasingly deployed in enclosures such as data centers, marine machinery spaces, and industrial process lines. This review summarizes application performance, discharge and distribution design, material compatibility, and byproduct control and maps practical gaps for large volume and ...
Zhilei Yu, Haibin Dong, Yanfeng Sheng, Xuelei Xian, Dehua Zhang, Feiran Li, Liang Liu, Junchao Zhao, Heping Zhang   +8 more
wiley   +1 more source

Real-World Assessment of Direct Oral Factor Xa Inhibitors: Dosing Appropriateness, Drug Exposure, and Inter-Platform Comparability of Chromogenic Anti-Xa Assays. [PDF]

Diagnostics (Basel)
Kim Y, Lee S, Park Y, Lee KA.
europepmc   +1 more source

Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study. [PDF]

Front Neurol, 2023
Doeppner TR, Olbricht L, Maxhuni T, Alhaj Omar O, Sachs UJ, Juenemann MB, Huttner HB, Gerner ST.   +7 more
europepmc   +1 more source

The impact of systemic long‐term medications for the development of age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 6, Page 674-681, September 2026.
Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä, Reijo Sund, Toni Rikkonen, Kai Kaarniranta   +3 more
wiley   +1 more source

Intracranial Hemorrhage in Patients Receiving Factor Xa Inhibitors: Challenges and Perspectives. [PDF]

Intern Med
Chatani R.
europepmc   +1 more source